{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:13:17Z","timestamp":1788801197428,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12185-026-04160-y","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:57:30Z","timestamp":1768820250000},"page":"916-923","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hearing loss in Langerhans cell histiocytosis: close association with central nervous system consequences"],"prefix":"10.1007","volume":"123","author":[{"given":"Akira","family":"Kaino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-538X","authenticated-orcid":false,"given":"Kenichi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Osone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shioda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Imashuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Japan Langerhans Cell Histiocytosis Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"4160_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/ped.12380","volume":"56","author":"A Morimoto","year":"2014","unstructured":"Morimoto A, Oh Y, Shioda Y, Kudo K, Imamura T. Recent advances in Langerhans cell histiocytosis. Pediatr Int. 2014;56:451\u201361.","journal-title":"Pediatr Int"},{"key":"4160_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/bjh.17243","volume":"192","author":"K Sakamoto","year":"2021","unstructured":"Sakamoto K, Morimoto A, Shioda Y, Imamura T, Kudo K, Ishida Y, et al. Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96\/02 studies. Br J Haematol. 2021;192:615\u201320.","journal-title":"Br J Haematol"},{"key":"4160_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27454","volume":"66","author":"K Sakamoto","year":"2019","unstructured":"Sakamoto K, Morimoto A, Shioda Y, Imamura T, Kudo K, Ishida Y, et al. Central diabetes insipidus in pediatric patients with Langerhans cell histiocytosis: results from the JLSG-96\/02 studies. Pediatr Blood Cancer. 2019;66:e27454.","journal-title":"Pediatr Blood Cancer"},{"key":"4160_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/pbc.20425","volume":"46","author":"N Grois","year":"2006","unstructured":"Grois N, P\u00f6tschger U, Prosch H, Minkov M, Aric\u00f2 M, Gadner H. Risk factors for diabetes insipidus in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2006;46:228\u201333.","journal-title":"Pediatr Blood Cancer"},{"key":"4160_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-9-16","volume":"9","author":"T Humphries","year":"2012","unstructured":"Humphries T, Kushalnagar P, Mathur G, Napoli DJ, Padden C, Rathmann C, et al. Language acquisition for deaf children: reducing the harms of zero tolerance to the use of alternative approaches. Harm Reduct J. 2012;9:16.","journal-title":"Harm Reduct J"},{"key":"4160_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/pbc.20021","volume":"42","author":"R Haupt","year":"2004","unstructured":"Haupt R, Nanduri V, Calevo MG, Ladenstein R, P\u00f6tschger U, Gadner H, et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society\u2014Late Effects Study Group. Pediatr Blood Cancer. 2004;42:438\u201344.","journal-title":"Pediatr Blood Cancer"},{"key":"4160_CR7","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/pbc.21145","volume":"48","author":"D Pollono","year":"2007","unstructured":"Pollono D, Rey G, Latella A, Zelazko M, Bogetti D, Dapueto J, et al. Reactivation and risk of sequelae in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007;48:696\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"4160_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/pbc.22186","volume":"54","author":"V Nanduri","year":"2010","unstructured":"Nanduri V, Tatevossian R, Sirimanna T. High incidence of hearing loss in long-term survivors of multisystem Langerhans cell histiocytosis. Pediatr Blood Cancer. 2010;54:449\u201353.","journal-title":"Pediatr Blood Cancer"},{"key":"4160_CR9","unstructured":"World Health Organisation (2021). World reports on hearing. Geneva: WHO. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240020481"},{"key":"4160_CR10","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.ijporl.2009.07.010","volume":"73","author":"I Saliba","year":"2009","unstructured":"Saliba I, Sidani K. Prognostic indicators for sensorineural hearing loss in temporal bone histiocytosis. Int J Pediatr Otorhinolaryngol. 2009;73:1616\u201320.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"4160_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/pbc.26212","volume":"64","author":"A Weiss","year":"2017","unstructured":"Weiss A, Sommer G, Kasteler R, Wengenroth L, Hirt A, Huber A, et al. Long-term auditory complications after childhood cancer: a report from the Swiss Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2017;64:364\u201373.","journal-title":"Pediatr Blood Cancer"},{"key":"4160_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.21985","volume":"107","author":"A Morimoto","year":"2006","unstructured":"Morimoto A, Ikushima S, Kinugawa N, Ishida Y, Yabe H, Kudo K, et al. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis. Cancer. 2006;107:613\u20139.","journal-title":"Cancer"},{"key":"4160_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12185-016-1993-3","volume":"104","author":"A Morimoto","year":"2016","unstructured":"Morimoto A, Shioda Y, Imamura T, Kudo K, Ishida Y, Sakamoto K, et al. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans cell histiocytosis study group-02 protocol study. Int J Hematol. 2016;104:99\u2013109.","journal-title":"Int J Hematol"},{"key":"4160_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12185-018-2444-0","volume":"108","author":"A Morimoto","year":"2018","unstructured":"Morimoto A, Shioda Y, Imamura T, Kudo K, Ishida Y, Sakamoto K, et al. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans cell histiocytosis study group-02 protocol study. Int J Hematol. 2018;108:192\u20138.","journal-title":"Int J Hematol"},{"key":"4160_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2471\/BLT.19.230367","volume":"97","author":"BO Olusanya","year":"2019","unstructured":"Olusanya BO, Davis AC, Hoffman HJ. Hearing loss grades and the International classification of functioning, disability and health. Bull World Health Organ. 2019;97:725\u20138.","journal-title":"Bull World Health Organ"},{"key":"4160_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/pbc.24367","volume":"60","author":"R Haupt","year":"2013","unstructured":"Haupt R, Minkov M, Astigarraga I, Sch\u00e4fer E, Rodriguez-Galindo C, Janka G, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60:175\u201384.","journal-title":"Pediatr Blood Cancer"},{"key":"4160_CR17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1067\/mpd.2001.111331","volume":"138","author":"H Gadner","year":"2001","unstructured":"Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, et al. A randomized trial of treatment for multisystem Langerhans\u2019 cell histiocytosis. J Pediatr. 2001;138:728\u201334.","journal-title":"J Pediatr"},{"key":"4160_CR18","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1182\/blood-2007-08-106211","volume":"111","author":"H Gadner","year":"2008","unstructured":"Gadner H, Grois N, P\u00f6tschger U, Minkov M, Aric\u00f2 M, Braier J, et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood. 2008;111:2556\u201362.","journal-title":"Blood"},{"key":"4160_CR19","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","volume":"121","author":"H Gadner","year":"2013","unstructured":"Gadner H, Minkov M, Grois N, P\u00f6tschger U, Thiem E, Aric\u00f2 M, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013;121:5006\u201314.","journal-title":"Blood"},{"key":"4160_CR20","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3174\/ajnr.A0509","volume":"28","author":"H Prosch","year":"2007","unstructured":"Prosch H, Grois N, Wnorowski M, Prayer D, Steiner M, Gadner H, et al. Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis. AJNR Am J Neuroradiol. 2007;28:1022\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4160_CR21","doi-asserted-by":"crossref","unstructured":"Imashuku S, Shioda Y, Kobayashi R, Morimoto A, Ishida Y, Kudo K, et al. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH study group. Haematologica. 2008;93:615\u20138.","DOI":"10.3324\/haematol.11827"},{"issue":"2790\u2013802","key":"4160_CR22","volume":"56","author":"CM Wilk","year":"2023","unstructured":"Wilk CM, Cathomas F, T\u00f6r\u00f6k O, Sinnreich M, Roider T, Weis S, et al. Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders. Immunity. 2023;56(2790\u2013802):e6.","journal-title":"Immunity"},{"key":"4160_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-444-62630-1.00001-9","volume":"129","author":"JO Pickles","year":"2015","unstructured":"Pickles JO. Auditory pathways: anatomy and physiology. Handb Clin Neurol. 2015;129:3\u201325.","journal-title":"Handb Clin Neurol"},{"key":"4160_CR24","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2147\/JIR.S492292","volume":"18","author":"M Yu","year":"2025","unstructured":"Yu M, Jiang WJ, Yu M, Liu JY, Hu YH, Li C, et al. The upregulation of IL-1\u03b2 induced by cisplatin triggers PI3K\/AKT\/MMP9 pathway in pericytes mediating the leakage of the blood labyrinth barrier. J Inflamm Res. 2025;18:1191\u2013205.","journal-title":"J Inflamm Res"},{"key":"4160_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/0194599817726326","volume":"157","author":"S Anne","year":"2017","unstructured":"Anne S, Lieu JEC, Cohen MS. Speech and language consequences of unilateral hearing loss: a systematic review. Otolaryngol Head Neck Surg. 2017;157:572\u20139.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"4160_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.22591","volume":"4","author":"T Arras","year":"2021","unstructured":"Arras T, Boudewyns A, Dhooge I, Offeciers E, Philips B, Desloovere C, et al. Assessment of receptive and expressive language skills among young children with prelingual single-sided deafness managed with early cochlear implantation. JAMA Netw Open. 2021;4:e2122591.","journal-title":"JAMA Netw Open"},{"key":"4160_CR27","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","volume":"34","author":"S H\u00e9ritier","year":"2016","unstructured":"H\u00e9ritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa S, et al. BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy. J Clin Oncol. 2016;34:3023\u201330.","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04160-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04160-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04160-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:08:36Z","timestamp":1782468516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04160-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4160"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04160-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}